Calliditas Therapeutics AB (publ) (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
18.50
+0.10 (0.54%)
At close: Apr 24, 2024, 4:00 PM
19.13
+0.63 (3.41%)
Pre-market: Apr 25, 2024, 4:21 AM EDT

CALT Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Net Income
-466.19-412.27-500.29-433.49-32.58-132.05
Other Operating Activities
31.53100.9138.71124.31-38.433.86
Operating Cash Flow
-434.66-311.35-461.59-309.18-71.01-128.19
Capital Expenditures
-12.79-2.51-6.590-0.120
Acquisitions
000-172.600
Change in Investments
-0.96-2.63-1.69-0.01-1.890
Other Investing Activities
00-16.07--16.07-
Investing Cash Flow
-13.75-5.14-24.34-172.61-18.070
Share Issuance / Repurchase
00324795.45197.65714.22
Debt Issued / Paid
226.28482.13193.95-3.97-1.65-0.47
Other Financing Activities
-26.6393.86-82.79-22.922.832.83
Financing Cash Flow
199.65575.99435.16768.56198.84716.57
Net Cash Flow
-248.75259.49-50.77286.77109.75588.38
Free Cash Flow
-447.44-313.87-468.18-309.18-71.13-128.19
Free Cash Flow Margin
-37.07%-39.09%-204.13%-35375.40%-38.48%-
Free Cash Flow Per Share
-15.02-10.62-18.75-13.36-3.07-
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).